222 related articles for article (PubMed ID: 31609143)
1. Downregulation of the circadian Period family genes is positively correlated with poor head and neck squamous cell carcinoma prognosis.
Li YY; Jin F; Zhou JJ; Yu F; Duan XF; He XY; Wang R; Wu WL; Long JH; Luo XL
Chronobiol Int; 2019 Dec; 36(12):1723-1732. PubMed ID: 31609143
[TBL] [Abstract][Full Text] [Related]
2. Circadian (De)regulation in Head and Neck Squamous Cell Carcinoma.
Rahman S; Kraljević Pavelić S; Markova-Car E
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151182
[TBL] [Abstract][Full Text] [Related]
3. Combined expression and prognostic significance of PPFIA1 and ALG3 in head and neck squamous cell carcinoma.
Zhou H; Cao T; Li WP; Wu G
Mol Biol Rep; 2019 Jun; 46(3):2693-2701. PubMed ID: 30805892
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of circadian clock genes in head and neck squamous cell carcinoma.
Hsu CM; Lin SF; Lu CT; Lin PM; Yang MY
Tumour Biol; 2012 Feb; 33(1):149-55. PubMed ID: 22081375
[TBL] [Abstract][Full Text] [Related]
5. Expression level of PD-L1 is involved in ALDH1A1-mediated poor prognosis in patients with head and neck squamous cell carcinoma.
Zhou AL; Wang X; Yu W; Yang L; Wei F; Sun Q; Wang Y; Kou F; Dong R; Ren X; Zhang X
Pathol Res Pract; 2020 Sep; 216(9):153093. PubMed ID: 32825960
[TBL] [Abstract][Full Text] [Related]
6. High expression of GPNMB predicts poor prognosis in head and neck squamous cell carcinoma.
Li H; Xiao Y; Wu CC; Yang LL; Cao LY; Chen DR; Zhou JJ; Zhang WF; Sun ZJ
Histol Histopathol; 2019 Jul; 34(7):803-810. PubMed ID: 30632601
[TBL] [Abstract][Full Text] [Related]
7. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma.
Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628
[TBL] [Abstract][Full Text] [Related]
8. PER1 and CLOCK: potential circulating biomarkers for head and neck squamous cell carcinoma.
Hsu CM; Lin PM; Lai CC; Lin HC; Lin SF; Yang MY
Head Neck; 2014 Jul; 36(7):1018-26. PubMed ID: 23784787
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of the expression and prognosis for CDCAs in head and neck squamous cell carcinoma.
Wu ZH; Fang M; Zhou Y
PLoS One; 2020; 15(7):e0236678. PubMed ID: 32716971
[TBL] [Abstract][Full Text] [Related]
10. BP180 Is a Prognostic Factor in Head and Neck Squamous Cell Carcinoma.
Meng X; Matsumoto F; Mori T; Miura N; Ino Y; Onidani K; Kobayashi K; Matsuzaki Y; Yoshimoto S; Ikeda K; Honda K
Anticancer Res; 2021 Feb; 41(2):1089-1099. PubMed ID: 33517320
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.
Liu Z; Zhang X; Huang D; Liu Y; Zhang X; Liu L; Li G; Dai Y; Tan H; Xiao J; Tian Y
Med Oncol; 2012 Dec; 29(5):3381-8. PubMed ID: 22815155
[TBL] [Abstract][Full Text] [Related]
12. Loss of the clock gene PER2 is associated with cancer development and altered expression of important tumor-related genes in oral cancer.
Xiong H; Yang Y; Yang K; Zhao D; Tang H; Ran X
Int J Oncol; 2018 Jan; 52(1):279-287. PubMed ID: 29115399
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of Per1, Per2 and Per3 and their prognostic relevance in non-small cell lung cancer.
Liu B; Xu K; Jiang Y; Li X
Int J Clin Exp Pathol; 2014; 7(11):7863-71. PubMed ID: 25550826
[TBL] [Abstract][Full Text] [Related]
14. Rh type C-glycoprotein functions as a novel tumor suppressor gene by inhibiting tumorigenicity and metastasis in head and neck squamous cell carcinoma.
Xu W; Zou H; Wei Z; Song C; Tang C; Yin X; Wang Y; Han S; Cai Y; Han W
Aging (Albany NY); 2019 Jun; 11(11):3601-3623. PubMed ID: 31170090
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of BASP1 Indicates a Poor Prognosis in Head and Neck Squamous Cell Carcinoma.
Jaikumarr Ram A; Girija As S; Jayaseelan VP; Arumugam P
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3435-3439. PubMed ID: 33247706
[TBL] [Abstract][Full Text] [Related]
16. Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma.
Sanada T; Islam A; Kaminota T; Kirino Y; Tanimoto R; Yoshimitsu H; Yano H; Mizuno Y; Okada M; Mitani S; Ugumori T; Tanaka J; Hato N
Laryngoscope; 2020 May; 130(5):E327-E334. PubMed ID: 31219623
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of nuclear ING3 expression and translocalization to cytoplasm promotes tumorigenesis and progression in head and neck squamous cell carcinoma (HNSCC).
Li X; Zhang Q; Zhang M; Luo Y; Fu Y
Histol Histopathol; 2020 Jul; 35(7):681-690. PubMed ID: 31886514
[TBL] [Abstract][Full Text] [Related]
18. A Study on the Correlations of the miR-31 Expression with the Pathogenesis and Prognosis of Head and Neck Squamous Cell Carcinoma.
Qiang H; Zhan X; Wang W; Cheng Z; Ma S; Jiang C
Cancer Biother Radiopharm; 2019 Apr; 34(3):189-195. PubMed ID: 30628842
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas.
Kolenda T; Guglas K; Kopczyńska M; Teresiak A; Bliźniak R; Mackiewicz A; Lamperska K; Mackiewicz J
Cells; 2019 Apr; 8(4):. PubMed ID: 31010087
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the relationship between GLUT family in the progression and immune infiltration of head and neck squamous carcinoma.
Li B
Diagn Pathol; 2023 Aug; 18(1):88. PubMed ID: 37542344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
